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Abstract
Nephropathic cystinosis is a lysosomal storage disorder caused by mutations in the CTNS
gene encoding cystine transporter cystinosin that results in accumulation of amino acid cys-
tine in the lysosomes throughout the body and especially affects kidneys. Early manifesta-
tions of the disease include renal Fanconi syndrome, a generalized proximal tubular
dysfunction. Current therapy of cystinosis is based on cystine-lowering drug cysteamine
that postpones the disease progression but offers no cure for the Fanconi syndrome. We
studied the mechanisms of impaired reabsorption in human proximal tubular epithelial cells
(PTEC) deficient for cystinosin and investigated the endo-lysosomal compartments of cysti-
nosin-deficient PTEC by means of light and electron microscopy. We demonstrate that
cystinosin-deficient cells had abnormal shape and distribution of the endo-lysosomal com-
partments and impaired endocytosis, with decreased surface expression of multiligand re-
ceptors and delayed lysosomal cargo processing. Treatment with cysteamine improved
surface expression and lysosomal cargo processing but did not lead to a complete restora-
tion and had no effect on the abnormal morphology of endo-lysosomal compartments. The
obtained results improve our understanding of the mechanism of proximal tubular dysfunc-
tion in cystinosis and indicate that impaired protein reabsorption can, at least partially, be
explained by abnormal trafficking of endosomal vesicles.
Introduction
Nephropathic cystinosis (MIM 219800) is an autosomal recessive disorder caused by mutations
in the CTNS gene encoding cystinosin, a lysosomal cystine transporter [1, 2]. Cystinosin is a
367-amino acid lysosomal membrane protein with predicted 7 transmembrane domains and
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two lysosomal targeting motifs located in the C-terminus and in the 5th cytosolic loop [3]. A sec-
ond isoform of cystinosin has been described, in which the C-terminal targeting motif is substi-
tuted by a longer sequence. This isoform has a different localization within the cell, being found
on the plasma membrane, in the lysosomes and on other cytosolic structures such as endoplas-
mic reticulum and Golgi apparatus [4, 5]. Cystinosin was demonstrated to act as a proton-
dependent transporter [6, 7], thus, effective cystine transport is strictly dependent on the acidic
pH inside the lysosomal lumen. Cystinosin deficiency results in lysosomal cystine accumulation
in all body organs and tissues. Treatment with cystine-lowering drug cysteamine forms the basis
of current therapy of cystinosis [2, 8]. Cysteamine enters the lysosome and splits cystine mole-
cule into cysteine and cysteine-cysteamine mixed disulphide. Both products can then be released
from the lysosome through cysteine and PQLC2 transporters respectively [9].
The most severe infantile nephropathic clinical form of cystinosis is typically associated
with mutations resulting in a complete loss of function of cystinosin [10]. Among the Cauca-
sians originating from the Northern Europe, the most prevalent mutation is a 57-kb deletion,
which affects the first 10 exons of the CTNS gene [1]. Cells deriving from patients bearing this
deletion express no cystinosin and accumulate cystine in the lysosomes in normal culturing
conditions [11].
The initial clinical manifestation of cystinosis developing during infancy is renal Fanconi
syndrome, a generalized renal proximal tubular dysfunction, characterized by polyuria and ab-
normal urinary loss of amino acids, glucose, low-molecular-weight (LMW) and intermediate
weight proteins and other solutes [2, 11, 12]. In humans, generalized aminoaciduria appears as
the first biochemical sign, already in a neonatal period followed by glucosuria, phosphaturia
and urinary loss of bicarbonate and proteins, gradually developing into a full-blown Fanconi
syndrome by ~6 months of age [13]. Later in life, untreated patients develop progressive renal
damage leading to the end-stage renal disease (ESRD) and multiple extra-renal complications
affecting eyes, endocrine organs, liver, muscles and central nervous system [2, 14, 15]. Treat-
ment with cysteamine prevents lysosomal accumulation of cystine, improves growth and post-
pones the progression of renal disease and the development extra-renal complications,
however, it offers no cure for renal Fanconi syndrome, although some improvement has been
reported in patients treated starting from the early age [14–18].
The mechanism of renal Fanconi syndrome in cystinosis is still not completely understood
[11]. Impaired apical transporter function was demonstrated in cultured proximal tubular cells
from cystinosis patients [19]. Reabsorption of proteins from the primary urine is performed by
endocytosis and is dependent on the concerted functioning of multiligand scavenger receptors
present on the apical surface of proximal tubules. Recent studies in cystinosis mouse model
(Ctns-/- mice) have shown a decreased expression of the multi-ligand receptors megalin and
cubilin at the proximal tubule apical surfaces associated with cell dedifferentiation [20, 21].
Therefore, the impaired reabsorption in the affected proximal tubules can result either from
the decreased expression of the multiligand receptors or from the impaired delivery of the re-
ceptors and, possibly, other transporters to the apical surface of proximal tubular cells due to
deficient vesicular trafficking and recycling. A combination of both pathological changes is
also possible. However, an accurate study of the endocytosis and vesicular trafficking in human
proximal tubular cells deficient for cystinosin has not been performed.
The major challenge in studying the pathogenesis of renal dysfunction in cystinosis during
many years was the absence of a suitable model. The first mouse model developed on a FVB/N
genetic background showed no signs of kidney disease despite pronounced cystine accumula-
tion in the kidney [22]. Subsequently, a novel murine model of cystinosis generated on a pure
C57BL/6 background showed signs of proximal tubulopathy and kidney failure and therefore
offered an opportunity for studying pathogenesis [23, 20, 21]. However, it remains unclear to
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which extent the pathogenic mechanisms described in mice can be extrapolated to human
proximal tubular cells, especially taking into account that renal phenotype in mice do not fully
replicate human disease [23]. Furthermore, it is not always conceivable to differentiate between
pathologic and compensative mechanisms in vivo [21].
In our study we examined the direct consequences of cystinosin deficiency on proximal tu-
bular reabsorption machinery in human proximal tubular cells after down-regulation of the
CTNS gene with specific siRNA and confirmed the results in proximal tubular cells derived
from patients with cystinosis. We found that the absence of cystinosin resulted in an acute dis-
organisation of endo-lysosomal compartments, with clustering of endocytotic vesicles in the
perinuclear region, decreased expression of multiligand receptors on the cell surface and de-
layed processing of the ligands. These data, together with our finding of abnormal co-localiza-
tion of late endosomal and lysosomal marker LAMP-1 with the motor protein kinesin-1 in
cystinosin-deficient cells, suggest that cystinosin functions as an important regulator of endo-
lysosomal dynamics. Thus, the absence of cystinosin might lead to a defective movement of en-
dosomes to the cell surface. Importantly, pre-treatment with cysteamine resulted in partial im-
provement of the surface expression of receptors and rescued ligand processing, but could not
restore the abnormal morphology of the endo-lysosomal compartments. Our work makes a
contribution to the understanding of pathological processes leading to the renal Fanconi syn-
drome in cystinosis and provides further directions for studying possible treatments of the dis-
ease aimed to restore the defective trafficking mechanisms.
Materials and Methods
Antibodies and reagents
Human recombinant GST-RAP was produced and isolated as previously described [24].
Chemical reagents of analytical grade or higher were from Sigma-Aldrich. The antibodies used
in this study include Alexa-488-conjugated anti-LAMP1 (Santa Cruz), anti-LAMP1 rabbit
monoclonal antibody (Cell Signaling), anti-GST (16B12) (Covance), anti-EEA1 (Cell Signal-
ing), anti-KIF5b (Millipore), anti-HA mouse monoclonal and rabbit polyclonal antibodies
(Covance). The Alexa-Fluor-488, Alexa-Fluor-568 and Alexa-Fluor-633 secondary antibodies
were from Life Technologies.
Cell culture and transfection
Human kidney proximal tubular epithelial HK-2 cells originate from the American Tissue
Type Collection (ATTC, USA) and were used to study the endocytosis previously [25]. Human
conditionally immortalized PTEC (ciPTEC) were obtained from living kidney cells exfoliated
into urine as described previously [26]. Proximal tubular cells were grown in DMEM-HAM’s
F12 culture medium (Lonza) supplemented with 10% foetal bovine serum (Gibco), 50 IU/mL
penicillin and 50 mg/mL streptomycin (Lonza). For ciPTEC, the medium was additionally sup-
plemented with 5 μg/ml of insulin, 5 μg/ml of transferrin, 5 ng/ml of selenium, 40 pg/ml of tri-
iodothyronine, 36 ng/ml of hydrocortisone and 10 ng/ml of EGF (all from Sigma) [26, 27].
HK-2 and ciPTEC cells were transfected with plasmid vectors using either TransIT-LT1
(Mirus Bio LLC) or jetPRIME (Polyplus Transfection), according to the manufacturer’s in-
structions, and incubated for 16–20 h before fixation.
Down-regulation of the CTNS gene
The siRNA oligonucleotides targeting CTNS gene were purchased from Dharmacon (ON--
TARGET plus SMART pool J-019914-05–08). HK-2 cells were transfected with siRNA using
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Dharmafect4 (Dharmacon) transfection reagent according to the manufacturer’s instruction
and incubated for 2 to 3 days before performing further experiments. Down-regulation was
confirmed by real-time RT-PCR using primers, specific for CTNS. Actin was used as a house-
keeping gene control.
Immunocytochemistry and confocal microscopy
For immunocytochemistry, cells grown on glass coverslips were fixed with 4% paraformalde-
hyde for 10 min at room temperature and washed once in PBS. Blocking reagent was added to
the cells for 20 min, followed by a 1 h incubation with appropriate concentrations of the prima-
ry antibodies in blocking reagent (0.5% BSA, 0.05% saponine, 50 mM NH4Cl, 0.02% NaN3 in
PBS). The cells were then washed with PBS and incubated with secondary antibodies (1:400)
and DAPI (1:1000) for detection of nuclei, diluted in blocking solution. The cells were washed
twice in PBS and once in ion-free water to remove salts. The coverslips were then mounted on
glass microscope slides (Carlo Erba, Italy) with Mowiol (Calbiochem). The samples were exam-
ined under either Zeiss LSM 710 or Zeiss Axiovert 100M confocal laser-scanning microscopes,
in both cases equipped with a 63X (NA 1.4) oil-immersion objective. 5–10 randomly chosen
fields were analyzed for each condition. For RAP uptake experiments, at least 150 individual
cells were analyzed for each time point. Image processing and analysis were performed using
ImageJ software. Fluorescence intensity was measured in green and red channels after subtract-
ing background inside a selected area corresponding to an individual cell. Microscopic images
were prepared for publication using ImageJ (http://rsb.info.hin.gov/ij/) and Adobe Photoshop
CS4 software for cropping. The measurement of the lysosomal size was performed as described
previously [28]. Lysosome diameter was measured using ImageJ software, with lysosomes ap-
proximated as circles with the size from 0.1 to 5.0 μm2. Thresholds were kept the same for
all images.
Electron microscopy
For electron microscopy, small pieces of cystinotic kidney biopsy described previously [29] and
control kidney biopsy available at the Pathology Department of Radboud University Medical
Centre (Nijmegen, The Netherlands) obtained from a subject without cystinosis or cystinosis
patient having Fanconi syndrome were fixed in 2.5% glutaraldehyde dissolved in 0.1 M sodium
cacodylate buffer, pH 7.4 overnight at 4°C and washed in the same buffer. The tissue fragments
were postfixed in palade-buffered 2% OsO4 for 1 h, dehydrated, and embedded in Epon 812
(Merck, Darmstadt, Germany). Ultrathin sections were cut on an ultratome (Leica, Reichert
Ultracuts, Wien, Austria), and contrasted with 4% uranyl acetate for 45 min and subsequently
with lead citrate for 4 min at room temperature. Sections were examined in a Jeol 1200 EX2
electron microscope (JEOL, Tokyo, Japan).
Endocytosis assay
Cells were serum-starved for 1 h and washed twice in cold PBS containing 1% BSA. The cells
were incubated for 30 min on ice with 2.5 μg/ml recombinant GST-RAP in serum-free medi-
um. To measure surface binding of the ligand, cells were washed with cold complete medium
and fixed in 4% paraformaldehyde. To assess the endocytosis, the cells were washed with com-
plete medium and incubated at 37°C to allow internalization of the ligand at the indicated
times. At the end of this incubation, the cells were briefly acid washed (150 mMNaCl, 10 mM
acetic acid, pH 3.5) and fixed.
Endo-Lysosomal Dysfunction in Cystinosis
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Megalin uptake and recycling assay
For the HA-Meg4 internalisation assay control and CTNS KD HK-2 cells were transiently
transfected with HA-Meg4 and pcDNA3-RAP, serum starved for 2 h at 37°C in serum-free
DMEM, washed twice in cold PBS with 1% BSA, chilled to 4°C, and incubated with the anti-
HA monoclonal antibody for indicated times in an ice/water bath, to label the cell surface. The
unbound antibody was rinsed off with cold HEPES-buffered DMEM, and the cells were incu-
bated in preheated complete medium for indicated times at 37°C. After internalisation, the an-
tibodies remaining on the cell surface were removed by a 30 s acid wash (150 mMNaCl,
10 mM acetic acid, pH 3.5), with a brief wash in PBS, and then the cells were fixed.
BSA degradation assay
Lysosomal degradation was measured as described previously [30]. Briefly, control and cysti-
nosis ciPTEC grown in glass-bottom cell culture chambers (LabTek) were incubated with
5 μg/ml DQ-BSA and 5 μg/ml Alexa-Fluor-555-BSA (Life Technologies) at 37°C for 2 h,
washed and analyzed under a confocal microscope. Cells treated with 100 nM of bafilomycin
A1 were used as a control.
Measurement of lysosomal pH
Control and cystinotic ciPTEC and control and CTNS KD HK-2 cells were loaded with 10 μM
of acridine orange for 15 min at 37°C, washed in HEPES-buffered complete medium and ana-
lyzed under a confocal microscope. Acridine orange was excited at 450–490 nm and the signal
recorded at 520–560 nm or>620 nm. Typically, 5–10 images were collected from 3 separate
experiments and the red/green ratio was calculated.
Results
Morphology of endosomal compartments is altered in cystinosin-
deficient cells
We studied the changes in the endo-lysosomal compartments in cystinosis using two working
models. First, we used human proximal tubular HK-2 cell line treated with siRNA specific to
the CTNS gene (CTNS KD). The efficacy of down-regulation was evaluated by real-time PCR
prior to each experiment and was 80% or higher after 2 days. The cystine accumulation was
not detectable after 2 days of down-regulation when the morphology and endocytosis assess-
ments were performed. After a prolonged 4-day exposure, HK-2 CTNS KD cells demonstrated
a ~7-fold (p<0.005) increase of cystine content in comparison to the control, confirming the
disrupted function of the transporter. However, the formation of the dense cobblestone-like
monolayer of HK-2 cells obstructed the imaging experiments at this time point. Next, we con-
firmed the results in ciPTEC that were established as described previously from living exfoliat-
ed cells extracted from urine of a cystinosis patient bearing the 57-kb deletion and of a healthy
volunteer [19].
To study the endosomal compartments, control and cystinosis ciPTEC cells and CTNS KD
HK-2 cells were stained with antibodies specific to markers of early endosomes and late endo-
somes/lysosomes (EEA1 and LAMP1 respectively), the ER (VAP-A), Golgi (GM130) and TGN
(TGN46). To measure the diameter of individual lysosomes, we used the method, described
previously [28]. Clustered lysosomes were excluded from the analysis by the size filtering. In
cystinosis ciPTEC, average size of the individual LAMP1-positive vesicles was enlarged by 35%
(p<0.01), and the vesicles demonstrated a different distribution pattern than in the ciPTEC
from a healthy donor (Fig. 1a). In HK-2 cells, accurate measurement of the lysosomal size was
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not feasible due to high level of clusterization of endosomal vesicles in the majority of CTNS
KD cells: EEA1-positive and LAMP1-positive vesicles were abnormally clustered in perinuclear
area (Fig. 1b). To estimate quantitatively the effect, two independent observers analyzed 2 dis-
tinct groups of cells, characterized by a ‘perinuclear’ localization of the vesicles, in which no la-
belled compartments were visible outside the compact perinuclear cluster, or by a ‘perinuclear
+peripheral’ localization, in which endosomes were distributed throughout the central and pe-
ripheral areas. The former phenotype was defined as cystinotic, and the latter—as normal,
since it was observed in most of the control HK-2 cells. In CTNS KD HK-2 cells, the number of
cells with perinuclear distribution of endosomes increased by more than 2 folds in comparison
with the control (Fig. 1c).
As cystinotic ciPTEC are characterized by a significant cystine accumulation under normal
culture conditions, we tested whether cystine-lowering treatment could rescue the abnormal
phenotype observed. Control and cystinosis ciPTEC cells were treated with 100 μM of cyste-
amine for 24 h. Such treatment was previously shown to decrease the cystine accumulation by
~91% without causing toxic effects on cultured cells. Longer treatment did not result in a sig-
nificant further decrease of cystine content (S1 Fig.). We found that the cysteamine treatment
had no significant effect on lysosomal size and distribution (Fig. 1a).
To confirm our in vitro findings, we performed electron microscopy study of a biopsy mate-
rial obtained from a cystinosis patient treated with cysteamine that was previously described
[29]. We found an increased number of electron-dense lysosomes clustered in the perinuclear
region in proximal tubular cells compared to control tissue samples (Fig. 1d).
To identify different endosomal compartments, we transfected control and CTNS KD HK-2
cells with GFP-tagged Rab GTPases, commonly used for this purpose [31–33]. The co-
localization of Rab5 and Rab7, corresponding to early and late endosomes, with EEA1 and
LAMP1 markers respectively, was unchanged, and no mixing of the different endocytic com-
partments was detected in CTNS KD cells. The subcellular localization of Rab6 and Rab9, cor-
responding to trans-Golgi network and late endosome-to-Golgi transport domains, was
also unaffected.
Distribution of kinesin-1 is altered in cystinosin-deficient cells
The perinuclear clustering of lysosomes suggested a possible involvement of the microtubule-
based motor protein kinesin-1 responsible for the transport of endosomal vesicles towards mi-
crotubules plus-end. Visualization of kinesin-1 with anti-kinesin-1 heavy chain B (KIF5b) anti-
bodies showed an altered subcellular localization of the protein in CTNS KD HK-2 cells as
compared to control cells. Moreover, a ~8-fold increase of co-localization of kinesin-1 with
LAMP1 was observed (Fig. 2a, b, p<0.001). Together these observations suggest that the al-
tered endosomal and lysosomal trafficking and distribution in cystinosin-deficient cells might
be explained by incorrect dynamics of lysosome-associated motor proteins, as discussed later.
Multiligand receptor-mediated endocytosis is impaired in cystinosin-
deficient cells
To estimate the surface expression of megalin, we used a recombinant GST-tagged RAP pro-
tein, which binds megalin with high affinity and has been used to study endocytosis in proxi-
mal tubular cells previously [25]. HK-2 or ciPTEC cells were incubated with exogenous
GST-RAP at 4°C for 30 minutes, fixed and stained with antibodies against GST to visualise sur-
face-bound GST-RAP. We found that surface binding of GST-RAP was reduced by ~30%
(p<0.05) in CTNS KD HK-2 cells (Fig. 3a, b) and by ~60% (p<0.01) in ciPTEC derived from a
cystinosis patient (Fig. 3c, d) as compared to control. These observations indicate a reduced
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Fig 1. Altered endosomal/lysosomal compartments in cystinosin-deficient cells. (a) Altered morphology of early and late endosomes in ciPTEC
deriving from the cystinosis patient: late endosomes appeared enlarged and abnormally clustered around the nuclei (*), and EEA1-positive endosomes
tended to cluster in perinuclear area rather than to spread throughout the cell as in control ciPTEC (arrows). Cysteamine treatment had no influence on the
abnormal phenotype in cystinotic cells. Scale bar = 10 μm. (b) Immunostaining with antibodies to early endosomal (EEA1) and late endosomal/lysosomal
(LAMP1) markers revealed altered morphology in CTNS KD HK-2 cells. Scale bar = 10 μm. (c) Number of cells with “cystinotic” phenotype (endosomes
clustered in perinuclear area and disappearance of peripheral vesicles) was quantified in CTNS KD cells; representation of 3 independent down-regulation
experiments (** p<0.01). (d) Transmitted electron microscopy of kidney biopsy material obtained from a cystinosis patient treated with cysteamine and a
control subject and. In cystinosis tissue, perinuclear localization of electron-dense lysosomes (asterisk) was demonstrated in PTEC. Scale bar = 3 μm.
doi:10.1371/journal.pone.0120998.g001
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surface expression of megalin in cells deficient for cystinosin. Treatment of cystinotic ciPTEC
with 100 μM of cystine-lowering drug cysteamine for 24 h resulted in a partial improvement of
GST-RAP surface binding (Fig. 3c, d).
To study endocytosis, cells pre-incubated with GST-RAP ligand were transferred to 37°C to
allow internalization of the ligand bound to the cell surface. At indicated time points, cells were
fixed and stained for GST-RAP. At earlier time points, the staining was visible in vesicular
structures corresponding to endosomes and then gradually disappeared. In CTNS KD HK-2
cells, GST-RAP remained visible for significantly longer time after internalization in compari-
son to controls (Fig. 4a).
Fig 2. Abnormal distribution of kinesin-1 motor protein in cystinosin-deficient cells. (a) Control and CTNS KD HK-2 cells were fixed and stained with
antibodies specific to KIF5b, a component of kinesin-1 complex, and LAMP1. CTNS KD cells had an abnormal distribution of kinesin-1 to LAMP1-positive
enlarged structures. Scale bar = 10 μm. (b) Co-localization analysis was performed using ImageJ JACoP plug-in on 50 control and CTNS KD cells. CTNS KD
cells had a 8-fold increase of co-localization between KIF5b and LAMP1 (*** p<0.001).
doi:10.1371/journal.pone.0120998.g002
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The observation was also confirmed in cystinotic ciPTEC (Fig. 4b). Importantly, pre-treat-
ment of cystinotic ciPTEC with 100 μM cysteamine for 24 h prior to the experiment partially
rescued the delayed cargo processing (Fig. 4b).
Decreased surface expression of megalin is associated with impaired
trafficking
To exclude the possibility that reduced megalin surface expression was caused by decreased ex-
pression of endogenous megalin in cystinosin deficient cells and to study megalin localization
and trafficking, we used HA-Meg4 mini-receptor construct transiently expressed in HK-2 cells.
Fig 3. Decreased surface expression of megalin in cystinosin-deficient cells. (a, b) Control and CTNS KD HK-2 cells were incubated with GST-RAP for
30 min on ice. As evaluated by fluorescence intensity of individual cells, surface expression of multiligand receptors was decreased in cystinosin-deficient
cells (* p<0.05). (c, d) ciPTEC cells from healthy donor and cystinosis patient were incubated with GST-RAP. Cystinotic cells demonstrated a decreased
surface expression of multiligand receptors (** p<0.01). Treatment of cystinotic and control ciPTECwith 100 μM cysteamine for 24 h partially restored
GST-RAP surface binding (* p<0.05). Scale bar = 10 μm.
doi:10.1371/journal.pone.0120998.g003
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Fig 4. Endocytic uptake and processing of GST-RAP ligand. (a) Control and CTNS KD HK-2 cells were incubated with GST-RAP for 30 min on ice and
then were allowed to internalize the ligand at 37°C for 15 and 45 min. GST-RAP processing was evaluated by the intensity of anti-GST staining with specific
antibodies at indicated time points. Degradation of the ligand was delayed in CTNS KD cells in comparison with the control, as expressed after normalization
of the signal to the initial value (surface binding at 0 min). (b) The observation was confirmed in control and cystinotic ciPTEC cells (** p<0.01 after 45 min).
Treatment with cysteamine resulted in partial rescue of the GST-RAP processing (* p<0.05 after 45 min). Scale bar = 10 μm.
doi:10.1371/journal.pone.0120998.g004
Endo-Lysosomal Dysfunction in Cystinosis
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This model has been successfully used for this purpose previously [25]. While no major differ-
ence in total HA-Meg4 expression was registered between control and CTNS KD cells, the sur-
face expression of HA-Meg4 was decreased by 30% in CTNS KD cells (p<0.05) as assessed by
measurement of fluorescence intensity after incubation of cells on ice with anti-HA antibodies
(Fig. 5a, b). After transferring the cells to 37°C, HA-Meg4 was internalized to endosomal vesi-
cles. More HA-Meg4 remained visible after 1 h inside CTNS KD cells, indicative of deficient re-
cycling of the receptor from the endosomes (Fig. 5c, d, p<0.01).
We next measured the expression of endogenous megalin in control and CTNS KD HK-2
cells by means of qPCR. The level of megalin expression was not reduced in cystinosin-
deficient cells in comparison with the control (Fig. 5e). Together these observations indicate
that the reduced surface expression of the receptor and impaired receptor-mediated endocyto-
sis in cystinosin-deficient cells are caused by deficient trafficking of megalin (and, probably,
other receptors) rather than decreased gene expression.
Impaired lysosomal degradation of fluorescently-labelled BSA in
cystinotic ciPTEC
To assess the endocytosis and processing of cargo, exclusively destined for lysosomal degrada-
tion, we performed a pulse-chase experiment in ciPTEC cells using fluorescently-labelled BSA
as a ligand. We used Alexa-555-labelled BSA to trace the internalization and trafficking togeth-
er with DQ-BSA green to visualize the lysosomal degradation sites. As expected, 555-BSA pro-
cessing was delayed in cystinosis cells in comparison with the control, leading to a prominent
accumulation after 2 hours. Strong DQ-BSA green fluorescence was observed in the same com-
partments where 555-BSA accumulation took place, identifying them as lysosomes (Fig. 6a).
At the same time, staining with acridine orange dye demonstrated that acidification of lyso-
somes and lysosome permeability were not impaired in cystinosin-deficient cells (Fig. 6b) [34].
Together these results indicate delayed processing of endocytic cargo and suggest that cysti-
nosin deficiency affects the surface pool of multiligand receptors that can explain reduced
protein reabsorption.
Discussion
In this paper we describe a detailed study of receptor-mediated endocytosis in two models of
human proximal tubular cells deficient for cystinosin and demonstrate an abnormal morphol-
ogy of endosomal and lysosomal compartments and defective endocytosis.
We used proximal tubular cells from adult kidney (HK-2 cells), in which cystinosin was
down-regulated by cystinosin-specific siRNA, and conditionally immortalized proximal tubu-
lar cells derived from urine of a cystinosis patient bearing a homozygous deletion of the CTNS
gene. Although using immortalized cell lines has several disadvantages, such as lower expres-
sion levels of proximal tubular receptors and transporters and difficulties to study cell prolifer-
ation rates, these models offered a possibility to explore the molecular events induced by the
acute or chronic loss of expression of cystinosin in human cells. Indeed, the acute down-
regulation of cystinosin induced in HK2 cells with specific siRNA allowed us to explore direct
consequences of cystinosin deficiency limiting, on the one side, the effects related to inter-
individual variability, which is intrinsic to the study of patients-derived (or animal model-
derived) cells [19], and, on the other side, effects linked to adaptation phenomena to cystinosin
deficiency, which are likely to be less developed in CTNS KD cells compared to cells derived
from patients or from Ctns-/- mice tissue. Furthermore, by comparing the two cystinosin defi-
ciency cell models (acute KD vs cells from patients) we had an opportunity to discriminate be-
tween direct and indirect consequences induced by the loss of function of the protein. We
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Fig 5. Impairedmegalin trafficking in cystinosin-deficient HK-2 cells. (a) Control and CTNS KD HK-2 cells transfected with HA-Meg4 mini-receptor were
incubated on ice with anti-HA monoclonal antibodies for 1 h, fixed and stained to visualize the surface HA-Meg4. The surface expression of the protein was
decreased in CTNS KD cells in comparison with the control, whereas total amount of HA-Meg4, revealed by staining of permeabilized cells with polyclonal
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found that cystinosin down-regulation leads to an acute disorganization of the endo-lysosomal
compartments characterized by the decreased expression of the endocytic receptors on the cell
surface, the delayed processing of the endocytic ligands, and the clustering of early and late en-
dosomes and lysosomes in the perinuclear region. Only some of these endocytic dysfunctions
could be rescued by cystine-lowering agent cysteamine. It therefore likely that cystinosin, next
to its cystine transporting activity, plays a role in cellular vesicle trafficking.
Being aware of the intrinsic limitations of using cell models to study complex pathogenic pro-
cesses, we were reassured in verifying that many of our findings in human cystinotic cells are in
concordance with those recently published in a mouse model of cystinosis [20, 21]. The most
important observation is the reduced surface expression of multi-ligand receptors megalin and
other receptors and transporters demonstrated in kidney tissue of the Ctns-/- mice [20, 21].
The surface expression of multiligand receptors is strictly dependent on their level of expres-
sion and on their correct trafficking from the ER and Golgi apparatus and on the recycling pro-
cesses [35]. During endocytosis, ligand-bound surface receptors are internalized into early and
then late endosomes where highly organized sorting processes take place. Molecules bound for
fast recycling to the cell surface are sorted into the recycling vesicles from the early endosomal
compartment. Slow recycling is going through early and late endosomes via a specialized Rab-
11-positive perinuclear compartment [35].
The reduced surface expression of these receptors has been reported by Raggi et al. as a con-
sequence of the dedifferentiation of proximal tubular cells from Ctns-/- mice, a process associ-
ated with an activation of the transcription factor ZONAB (zonula occludens (ZO-1)-
associated nucleic binding protein), which promotes cell proliferation and directly inhibits the
expression of megalin and cubilin. However, it remained uncertain whether the activation of
proliferation program is an initial pathogenic event triggered by the absence of cystinosin or a
compensatory mechanism aiming to replenish cell losses. In our study we report that the acute
down-regulation of the CTNS gene primarily reduced surface expression of megalin without af-
fecting the total levels of this protein, thus suggesting a role of cystinosin in directing
megalin trafficking.
Interestingly, the reduced expression on the cell surface could be partially rescued already
after 24 hours of cysteamine treatment in cystinotic ciPTEC cells that were shown to accumu-
late significant amounts of cystine under normal culture conditions [19]. In addition to mis-
trafficking at the level of the early-recycling endosomal compartments we found that
cystinosin depletion induced alterations in the late endosomal/lysosomal compartments. These
include a delayed degradation of lysosomal substrates and a mislocalization of late endosomes/
lysosomes.
The impaired degradation capacity of lysosomes had previously been reported both in pa-
tients with cystinosis [36] and in animal models, although no overt evidence of lysosomal en-
zyme deficiency has been demonstrated [36, 20]. Interestingly, cysteamine almost completely
restored delayed cargo processing pointing to the important role of the lysosomal cystine stor-
age in this cellular defect. The impaired degradation capacity of the lysosomes was accompa-
nied by the mislocalization of these organelles that appear clustered in the perinuclear area.
Looking for the causes underlying this phenomenon we investigated the impact of the CTNS
antibodies, remained unchanged. (b) Quantification of fluorescence intensity (2 independent experiments, * p<0.05). (c) Internalization of HA-Meg4 was
allowed by moving the cells to 37°C for indicated time points. Images taken after 1 h reveal more HA-Meg4-positive vesicles in CTNS KD cells indicative of
deficient recycling of the protein. (d) Measurement of fluorescent intensity after 1 h demonstrated that less HA-Meg4 was internalized in CTNS KD cells at the
early time point, but more protein remained visible after 1 h (2 independent experiments, ** p<0.01). (e) qPCR analysis of endogenous megalin expression
in control and CTNS KD HK-2 cells, average data from 4 independent experiments.
doi:10.1371/journal.pone.0120998.g005
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Fig 6. Lysosomal degradation is impaired in cystinosis cells. (a) Trafficking and degradation of endocytic cargo was evaluated by means of fluorescently
labelled Alexa-555-BSA and fluorogenic substrate DQ-BSA: control and cystinotic ciPTEC cells were incubated with 5 μg/ml of each substrate for 2 h,
washed and analyzed under confocal microscope (live imaging). Quantification of fluorescence intensity showed no decrease in DQ-BSA degradation in
cystinotic cells. Incubation of cells with 5 μg/ml of fluorescently labelled 555-BSA for 2 h resulted in a prominent accumulation of the substrate in cystinotic
cells in comparison with the control. Scale bar = 10 μm. (b) Staining with acidophilic dye acridine orange (AO) demonstrated normal acidification of
lysosomes in cystinosin-deficient cells. Quantification of lysosomal pH by the acridine orange green/red fluorescence intensity revealed no difference
between cystinosin-deficient and control cells.
doi:10.1371/journal.pone.0120998.g006
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knock-down on motors and their regulators involved in late endosomal and lysosomal motility.
Lysosomes undergo bidirectional trafficking along microtubules driven by minus-end and
plus-end directed motors [37]. As the motor protein kinesin-1 mediates the plus-end (i.e. pe-
riphery) directed motility, we investigated whether an impaired association of kinesin-1 with
lysosomes could be responsible for their perinuclear clustering. In fact we found that kinesin-1
was even more associated to lysosomes in cystinosin-depleted cells as compared to control
cells, thus discarding the possibility that the cystinosis defect impairs the binding of plus-end
directed motor to its cargoes. Interestingly, the potential involvement of kinesins in the patho-
genesis of proximal tubular dysfunction has recently been demonstrated in Dent’s disease (an-
other condition presenting with renal Fanconi syndrome) via a direct interaction between ClC-
5 chloride-proton exchanger and another kinesin family member kinesin-2 (KIF3B) [38].
Different alternative possibilities can be considered. Firstly, the perinuclear clustering of ly-
sosomes may be due to the inability to anchor them at the cell periphery. This anchoring is
achieved by at least two different means: one involving the switch of lysosomes and of lyso-
some-related organelles from microtubule tracks to peripheral microfilament meshwork [37]
and the other involving the cholesterol-regulated contact sites between lysosomes and the ER
involving ORP1L [39]. The microtubule-actin meshwork switch is driven by the small GTPase
Rab27 and the actin-based motor myosin Va [40, 41]. Interestingly, we found that cystinosin
depletion reduced the mRNA levels for Rab27 by 40% (data not shown), and Johnson et al.
found that the endocytic defects can be partially corrected by overexpression of Rab27 in cells
from Ctns-/- mice that also show lower Rab27 levels as compared to control [42]. These results
suggest that a defective peripheral anchoring may underlie the perinuclear clustering of lyso-
somes in cystinosin-deficient cells. Alternatively, a possible alteration in cholesterol content of
cystinosin-depleted lysosomes might impair the ORP1-mediated peripheral anchoring of lyso-
some to the ER.
The relationships existing between the functional impairment and the altered positioning of
lysosomes in cystinosis remain an important subject for future studies.
Supporting Information
S1 Fig. Depletion of cystine accumulation in cystinosis ciPTEC cells in course of prolonged
treatment with cysteamine. ciPTEC cells were incubated for indicated time points with
100 μM of cysteamine. Cysteamine-containing culture medium was refreshed daily. Cystine
content of each sample was normalized by protein concentration and expressed as % of the ini-
tial. The graph represents averaged data from 2 different cystinosis ciPTEC lines deriving from
patients bearing a homozygous 57 kb deletion of the CTNS gene.
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